Translate this page into:
Year End Message
*Corresponding author: Dr. Prashant Mehta, Department of Medical Oncology, Hematology and Blood and Marrow Transplant, Amrita Institute of Medical Sciences and Research, Faridabad, Haryana, India. prashantm@fbd.amrita.edu
-
Received: ,
Accepted: ,
How to cite this article: Mehta P. Year End Message. Int J Mol Immuno Oncol. 2024;9:67. doi: 10.25259/IJMIO_35_2024
Dear Readers,
As we near the end of another remarkable year, I want to take a moment to share my heartfelt appreciation for everyone who makes this journal possible and meaningful.
Each issue of the International Journal of Molecular and Immuno Oncology results from a dedicated team’s tireless efforts. From the authors who share their groundbreaking research to the reviewers who lend their invaluable expertise to the editorial and publishing staff who bring it all together seamlessly. This is truly a collective achievement.
Our readers, thank you for your continued support and engagement. Your curiosity and commitment to advancing science inspire us to work harder with each issue. As we move into 2024, we focus on growing the journal’s reach, enhancing its quality, and ensuring it remains a trusted source of cutting-edge discoveries in molecular immune-oncology.
On behalf of the editorial team, I wish you a joyful holiday season and a wonderful New Year. Let’s look forward to another year of innovation, collaboration, and progress in our shared mission to advance science and healthcare.
With Best Wishes
Prashant Mehta
Editor-in-chief
